期刊文献+

1例川崎病合并阿司匹林哮喘患儿的药学监护

Pharmaceutical care for one child with Kawasaki disease combined with aspirin asthma
原文传递
导出
摘要 临床药师通过参与1例川崎病合并阿司匹林哮喘患儿的治疗过程,探讨和分析川崎病合并支气管哮喘患儿使用阿司匹林的安全性。临床药师参与制定个体化给药方案,对患儿药物治疗过程实行药学监护,保障了患儿用药的安全性和有效性。临床药师将药学理论知识和循证药学的知识与临床实践相结合,提高了药物治疗水平。 We analyzed the safe use of aspirin in children with Kawasaki disease combined with bronchial asthma by participating in the treatment process of one child with aspirin asthma and Kawasaki disease. Clinicalpharmacists participated in setting up individualized dosage regimen, provided pharmaceutical monitoring, and ensured the children's safety and effectiveness of drug use. Clinical pharmacists properly combine the theoretic knowledge and evidence-based medicine in clinical practice to improve the efficacy drug treatment.
作者 雷伟 董栋 张伟 LEI Wei;DONG Dong;ZHANG Wei(Department of Pharmacy,Women and Children's Hospital of Zhengzhou,Zhengzhou 450013;Department of Pediatrics,Women and Children's Hospital of Zhengzhou,Zhengzhou 450013)
出处 《中南药学》 CAS 2018年第8期1088-1091,共4页 Central South Pharmacy
关键词 支气管哮喘 川崎病 药学监护 阿司匹林哮喘 bronchial asthma Kawasaki disease pharmaceutical care aspirin asthma
  • 相关文献

参考文献8

二级参考文献73

  • 1杜军保.进一步提高川崎病的临床诊疗水平[J].中华儿科杂志,2006,44(5):321-323. 被引量:96
  • 2张清友,杜军保.不完全川崎病的诊治现状[J].中华儿科杂志,2006,44(5):339-341. 被引量:149
  • 3Research Committee on Kawasaki Disease Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki Disease [ C ]. Tokyo:J Ministry of Health and Welfare, 1984.
  • 4Park YW, Han JW, Park IS, et al. Epidemiologic features of Kawasaki disease in Korea 2000 - 2002 [J]. Pediatr lnt, 2005,47 ( 4 ) : 382 - 387.
  • 5Ng YM, Sung RY, So LY,et al. Kawasaki disease in Hong Kong, 1994 to 2000[ J]. Hong Kong Med J,2005,11 (5) :331 -335.
  • 6Heaton P, Wilson N, Nicholson R, et al. Kawasaki disease in New Zealand [ J ]. J Paediatr Child Health,2006,42 (4) : 184 - 190.
  • 7Du ZD,Zhao D,Du J,et al.Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004.Pediatr Infect Dis J,2007,26:449-451.
  • 8Newburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment,and long-term management of Kawasaki dsease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis,and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association.Pediatrics,2004,114:1708-1733.
  • 9Muta H,Ishii M,Egami K,et al.Early intravenous gammaglobulin treatment for kawasaki disease:the nationwide surveys in Japan.J Pediatr,2004,144:496-499.
  • 10Han RK,Silverman ED,Newman A,et al.Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease.Arch Pediatr Adaleac Med,2000,154:694-699.

共引文献3463

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部